|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,425.50 JPY | +3.37% |
|
-0.10% | +11.65% |
| Market Cap | 1,140B 7.01B 6.14B 5.68B 5.22B 9.87B 676B 10.03B 67.41B 26.56B 331B 26.34B 25.76B | P/E 2027 * |
16.1x | P/E 2028 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise Value | 941B 5.79B 5.07B 4.69B 4.31B 8.14B 558B 8.28B 55.62B 21.91B 273B 21.73B 21.26B | EV / Sales 2027 * |
2.07x | EV / Sales 2028 * | 2.07x |
| Free-Float |
80.98% | Yield 2027 * |
3.23% | Yield 2028 * | 3.2% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +3.37% | ||
| 1 week | -0.10% | ||
| Current month | +1.57% | ||
| 1 month | +7.85% | ||
| 3 months | +0.79% | ||
| 6 months | +8.11% | ||
| Current year | +11.65% |
| 1 week | 2,344.5 |  | 2,451 |
| 1 month | 2,318.5 | | 2,507 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,579.5 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 4,019 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.37% | -0.10% | +51.64% | -4.77% | 7.02B | |
| +1.23% | +1.08% | +15.52% | +80.84% | 48.15B | |
| -0.23% | -1.65% | +67.15% | +109.36% | 35.59B | |
| +1.61% | +0.15% | -2.75% | +39.18% | 11.9B | |
| +0.46% | -0.16% | +17.85% | +89.14% | 11.85B | |
| -0.37% | +2.49% | +34.42% | +136.73% | 9.31B | |
| -0.42% | -1.32% | +16.96% | +35.57% | 6.91B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +0.18% | -1.90% | +0.63% | +211.00% | 6.55B | |
| +0.13% | +0.48% | -31.42% | +17.36% | 6.13B | |
| Average | +0.60% | -0.32% | +18.89% | +79.38% | 15.02B | |
| Weighted average by Cap. | +0.63% | -0.56% | +27.39% | +85.64% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.79B 2.45B 2.26B 2.08B 3.93B 270B 4B 26.87B 10.58B 132B 10.5B 10.27B | 444B 2.73B 2.4B 2.22B 2.04B 3.85B 264B 3.91B 26.29B 10.36B 129B 10.27B 10.05B |
| Net income | 70.97B 437M 383M 354M 325M 614M 42.11B 624M 4.2B 1.65B 20.62B 1.64B 1.6B | 62.51B 385M 337M 312M 287M 541M 37.09B 550M 3.7B 1.46B 18.16B 1.44B 1.41B |
| Net Debt | -199B -1.23B -1.07B -993M -913M -1.72B -118B -1.75B -11.78B -4.64B -57.88B -4.6B -4.5B | -218B -1.34B -1.18B -1.09B -1B -1.89B -129B -1.92B -12.91B -5.08B -63.41B -5.04B -4.93B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-17 | JP¥2,425.50 | +3.37% | 2,057,200 |
| 26-07-16 | JP¥2,346.50 | -1.76% | 1,579,900 |
| 26-07-15 | JP¥2,388.50 | -1.81% | 1,516,100 |
| 26-07-14 | JP¥2,432.50 | +1.33% | 1,327,200 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
